Organon & Co. (OGN)

NYSE: OGN · Pharmaceutical Preparations · Jersey City, NJ · filing with the SEC since 2020

Grade5.4

◀ Past 6.6● Present 5.9▶ Future 3.6

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Filings

142 filings since 2017 beside 322 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026

Due nextLarge accelerated filer

10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027

10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 120 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included

4856773896977

2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Jun 11, 2026.SEC letters: 5 in the last 36 months, the newest Jun 25, 2024.

Insider forms 322

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk

Oct 30, 2026 10-Q Quarterly report Sep 30, 2026

Oct 30, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report

Aug 14, 2026 SCHEDULE 13G Large holder notice

Jul 31, 2026 SCHEDULE 13G/A Large holder update, amended

Jul 31, 2026 10-Q Quarterly report Jun 30, 2026

Jul 31, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report

Jul 23, 2026 8-K item 5.07 Shareholder vote · Current report

Jul 17, 2026 DEFA14A Extra proxy material

Jul 17, 2026 8-K item 8.01 Other event · Current report

Jun 17, 2026 DEFM14A Merger proxy statement

Jun 11, 2026 DEFA14A Extra proxy material

Jun 11, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 9, 2026

Jun 1, 2026 PREM14A Preliminary merger proxy May 29, 2026

May 29, 2026 SD Conflict minerals report

May 4, 2026 10-Q Quarterly report Mar 31, 2026

Apr 30, 2026 SCHEDULE 13G Large holder notice

Apr 30, 2026 DEFA14A Extra proxy material

Apr 30, 2026 8-K items 2.02, 9.01 Results released · Current report

Apr 29, 2026 SCHEDULE 13G Large holder notice

Apr 27, 2026 DEFA14A Extra proxy material

Apr 27, 2026 8-K items 1.01, 5.02, 7.01, 9.01 Major agreement signed; Officer or director change; Investor disclosure (Regulation FD) · Current report Apr 26, 2026

Apr 24, 2026 ARS Annual report to shareholders Dec 31, 2025

Apr 24, 2026 DEFA14A Extra proxy material

Apr 24, 2026 DEF 14A Proxy statement Jun 9, 2026

Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended

Feb 24, 2026 10-K Annual report Dec 31, 2025

Feb 20, 2026 8-K items 8.01, 9.01 Other event · Current report

Feb 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report

Nov 10, 2025 10-Q Quarterly report Sep 30, 2025

Nov 10, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report

Nov 10, 2025 10-Q/A Quarterly report, amended Jun 30, 2025

Nov 10, 2025 10-Q/A Quarterly report, amended Mar 31, 2025

Nov 10, 2025 10-K/A Annual report, amended Dec 31, 2024

Nov 7, 2025 8-K item 5.02 Officer or director change · Current report Nov 3, 2025

Oct 30, 2025 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended Oct 26, 2025

Oct 30, 2025 SCHEDULE 13G/A Large holder update, amended

40 of 142 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton OGN · research, not advice